Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
1,108
+25
+2% +$8.56K 0.07% 53
2026
Q1
$381K Sell
1,083
-50
-4% -$17.8K 0.07% 44
2025
Q4
$371K Buy
1,133
+227
+25% +$72K 0.06% 49
2025
Q3
$256K Sell
906
-253
-22% -$73.4K 0.05% 61
2025
Q2
$324K Buy
1,159
+456
+65% +$129K 0.07% 48
2025
Q1
$219K Buy
+703
New +$208K 0.05% 74
2024
Q4
Sell
-700
Closed -$226K 75
2024
Q3
$226K Hold
700
0.06% 71
2024
Q2
$219K Buy
+700
New +$206K 0.06% 65
2024
Q1
Sell
-700
Closed -$202K 70
2023
Q4
$202K Buy
+700
New +$191K 0.06% 65
2021
Q1
Sell
-797
Closed -$203K 28
2020
Q4
$203K Buy
+797
New +$184K 0.13% 29
2019
Q2
Sell
-717
Closed -$136K 28
2019
Q1
$136K Buy
+717
New +$137K 0.1% 21

Other funds holding AMGN

New World Advisors's AMGN Position: Q2 2026 in Review

New World Advisors increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $8.56K and bringing the position to 1,108 shares worth $401K. The position accounts for 0.07% of the portfolio, ranked #53.

New World Advisors first reported a position in AMGN in Q1 2019 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • New World Advisors held 1,108 shares of Amgen worth $401K as of Q2 2026.
  • New World Advisors bought 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.07% of New World Advisors's portfolio in Q2 2026, its #53 holding.
  • New World Advisors first reported a position in Amgen in Q1 2019 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on New World Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.